½ÃÀ庸°í¼­
»óǰÄÚµå
1599382

¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß 5G ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­-ÄÄÆÛ³ÍÆ®º°, ÃÖÁ¾ ¿ëµµº°, ¿ëµµº°, Áö¿ªº° Àü¸Á°ú ¿¹Ãø(2024-2031³â)

Global 5G In Healthcare Market Size, Share & Trends Analysis Report By Component (Hardware and Services), By End Use, By Application, By Regional Outlook and Forecast, 2024 - 2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: KBV Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 265 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß 5G ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È 39.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ½ÃÀåÀÌ ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2031³â±îÁö 6,273¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¼ºÀå ¿äÀÎ

ÃÖ±Ù °Ç°­ °ü¸®ÀÇ Á¦°ø ¹æ¹ý¿¡ Çõ¸íÀ» °¡Á®¿Â 5G ±â¼úÀÇ º¯Çõ ´É·Â¿¡ °ßÀÎµÇ¾î ¿ø°Ý ÀÇ·á ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á´Â ¿ø°ÝÁö¿¡¼­ÀÇ ÀÇ·á Á¦°ø¿¡ ÇʼöÀûÀÎ °ÍÀÌ µÇ¾î, ÇコÄÉ¾î ½Ã¼³¿¡ÀÇ Á÷Á¢ ¹æ¹®ÀÇ Çʿ伺ÀÌ ¾ø¾îÁ³½À´Ï´Ù.

¶ÇÇÑ 5G ±â¼úÀ» Ȱ¿ëÀ¸·Î ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÌ »õ·Î¿î ¼öÁØ¿¡ µµ´ÞÇÏ¿© »ç½Ç»ó ¾îµð¿¡¼­³ª ÇコÄÉ¾î ½Ã¼³·Î ȯÀÚ µ¥ÀÌÅ͸¦ Áö¼ÓÀûÀ¸·Î Àü¼ÛÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿þ¾î·¯ºí µð¹ÙÀ̽º, ¼¾¼­ ¹× ±âŸ ¸ð´ÏÅ͸µ ±â±âÀÇ µ¥ÀÌÅÍ ²÷±è ¾ø´Â º¯¼Ó±â´Â 5G ³×Æ®¿öÅ©ÀÇ Ãʰí¼Ó ¹× ÃÖ¼ÒÇÑÀÇ Áö¿¬À» ÅëÇØ º¸ÀåµË´Ï´Ù. ÀÌó·³ ¸¸¼ºÁúȯÀÇ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú È¿°úÀûÀÎ °ü¸®¸¦ °¡´ÉÄÉ ÇÔÀ¸·Î½á 5G´Â ÇコÄɾîÀÇ Á¤¼¼¸¦ È® ¹Ù²Ù°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

ÀÌ ºÐ¾ßÀÇ Àü°³¿¡´Â ¸¹Àº µ·ÀÌ µé¾î°¡±â ¶§¹®¿¡ ±¤¹üÀ§ÇÑ µµÀÔÀÌ ¾î·Á¿öÁú ¼ö ÀÖ½À´Ï´Ù. °ß°íÇÑ 5G ÀÎÇÁ¶ó¸¦ È®¸³ÇÏ·Á¸é ¿øÈ°ÇÑ ¿¬°á°ú Ä¿¹ö¸®Áö¸¦ È®º¸Çϱâ À§ÇØ ´Ù¼öÀÇ ±âÁö±¹°ú Ư¼ö ³×Æ®¿öÅ© Çϵå¿þ¾î¸¦ ¼³Ä¡ÇØ¾ß ÇÕ´Ï´Ù. ±× ¶§¹®¿¡, Ãʱâ ÀÎÇÁ¶ó ºñ¿ëÀÇ ³ôÀÌ´Â, ÇコÄÉ¾î ºÐ¾ß 5GÀÇ ±¤¹üÀ§ÇÑ µµÀÔ¿¡ ´ëÇÑ Å« À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÄÄÆ÷³ÍÆ® Àü¸Á

ÄÄÆ÷³ÍÆ®¸¦ ±â¹ÝÀ¸·Î ½ÃÀåÀº Çϵå¿þ¾î¿Í ¼­ºñ½º·Î ³ª´µ¾îÁ® ÀÖ½À´Ï´Ù. Çϵå¿þ¾î ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 67%ÀÇ ¼öÀÍ °øÀ¯¸¦ ¹Þ¾Ò½À´Ï´Ù. º´¿øÀ̳ª ÇコÄÉ¾î ½Ã¼³¿¡¼­´Â °í¼Ó ¿¬°á°ú ¿øÈ°ÇÑ µ¥ÀÌÅÍ º¯¼Ó±â¸¦ Áö¿øÇϱâ À§ÇØ 5G Áö¿ø IoT µð¹ÙÀ̽º, ¶ó¿ìÅÍ, Áø´Ü Àåºñ µî °í±Þ Çϵå¿þ¾î ±¸¼º ¿ä¼Ò°¡ ÇÊ¿äÇÕ´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú ¿þ¾î·¯ºí Çコ µð¹ÙÀ̽º¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸é¼­ 5G Çϵå¿þ¾î¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµ Àü¸Á

ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ½ÃÀåÀº °Ç°­ °ü¸® Á¦°ø¾÷ü, °Ç°­ º¸ÇèÀÚ ¹× ±âŸ·Î ºÐ·ùµË´Ï´Ù. ÇコÄÉ¾î º¸ÇèÀÚ ºÎ¹®Àº 2023³â¿¡ ½ÃÀå¿¡¼­ 24%ÀÇ ¼öÀÍ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. º¸Çè»ç¿Í ´Ù¸¥ º¸ÇèÀÚµéÀº ½Ç½Ã°£ µ¥ÀÌÅÍ Æ®·£½º¹Ì¼Ç°ú AI ÁÖµµ ÀλçÀÌÆ®¸¦ Ȱ¿ëÇØ û±¸ ó¸®, ºÎÁ¤ °ËÃâ, ȸ¿ø ¼­ºñ½º¸¦ °³¼±Çϱâ À§ÇØ 5G¸¦ äÅÃÇϰí ÀÖ½À´Ï´Ù.

¿ëµµ Àü¸Á

¿ëµµº°·Î º¸¸é, ½ÃÀåÀº ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, Ä¿³ØÆ¼µå ÀÇ·á±â±â, AR/VR, Ä¿³ØÆ¼µå ±¸±ÞÂ÷, ÀÚ»ê ÃßÀûÀ¸·Î ³ª´µ¾îÁ® ÀÖ½À´Ï´Ù. AR/VR ºÎ¹®Àº 2023³â¿¡ ½ÃÀå¿¡¼­ 13%ÀÇ ¼öÀÍ Á¡À¯À²À» ȹµæÇß½À´Ï´Ù. ÀÌ ºÎ¹®Àº ȯÀÚ Ä¡·á, ¿Ü°ú ¼ö¼ú ½Ã¹Ä·¹À̼Ç, ÀÇ·á ÈÆ·Ã¿¡¼­ÀÇ Áõ°­ Çö½Ç°ú °¡»ó Çö½ÇÀÇ ÀÌ¿ë Áõ°¡¿¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. 5GÀÇ °í´ë¿ªÆø°ú ÀúÁö¿¬À¸·Î AR/VR ¾ÖÇø®ÄÉÀ̼ÇÀº ·Îº¿¼ö¼ú ¹× °¡»óÁøÂû¿¡ ÇʼöÀûÀÎ ¸ôÀÔÇü ½Ç½Ã°£ °æÇèÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î º¼ ¶§ ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ °ÉÃÄ ºÐ¼®µÇ°í ÀÖ½À´Ï´Ù. À¯·´ ºÎ¹®Àº 2023³â¿¡ ½ÃÀå¿¡¼­ 32%ÀÇ ¼öÀÍ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. À¯·´ ±¹°¡¿¡¼­´Â ¿ø°ÝÀǷḦ °­È­ÇÏ°í º´¿øÀÇ ¿öÅ©Ç÷ο츦 ÃÖÀûÈ­ÇÏ¸ç °øµ¿Á¶»ç¿Í µ¹º½ Á¦°øÀ» À§ÇÑ ±¹°æÀ» ÃÊ¿ùÇÑ µ¥ÀÌÅÍ °øÀ¯¸¦ ÃËÁøÇϱâ À§ÇØ 5G ´ëÀÀ ±â¼ú äÅÃÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§ ¹× Á¶»ç ¹æ¹ý

  • ½ÃÀåÀÇ Á¤ÀÇ
  • ¸ñÀû
  • ½ÃÀå ¹üÀ§
  • ¼¼ºÐÈ­
  • Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå ¿ä¶÷

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå °³¿ä

  • ¼­¹®
    • °³¿ä
      • ½ÃÀ屸¼º ¹× ½Ã³ª¸®¿À
  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
    • ½ÃÀåÀÇ °úÁ¦

Á¦4Àå °æÀï ºÐ¼®-¼¼°è

  • KBV Cardinal Matrix
  • ÃÖ±Ù ¾÷°è ÀüüÀÇ Àü·«Àû Àü°³
    • ÆÄÆ®³Ê½Ê, Çù¾÷ ¹× °è¾à
    • Á¦Ç° Ãâ½Ã ¹× Á¦Ç° È®´ë
    • Àμö ¹× ÇÕº´
  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • ÁÖ¿ä ¼º°ø Àü·«
    • ÁÖ¿ä Àü·«
    • ÁÖ¿ä Àü·«Àû ¿òÁ÷ÀÓ
  • Porter's Five Forces ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß 5G ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ¼¼°èÀÇ Çϵå¿þ¾î ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ¼­ºñ½º ½ÃÀå : Áö¿ªº°

Á¦6Àå ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß 5G ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ¼¼°èÀÇ ÀÇ·á Á¦°øÀÚ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ÇコÄÉ¾î º¸ÇèÀÚ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ´Ù¸¥ ÃÖÁ¾ ¿ëµµ ½ÃÀå : Áö¿ªº°

Á¦7Àå ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß 5G ½ÃÀå : ¿ëµµº°

  • ¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ AR/VR ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ Ä¿³ØÆ¼µå ±¸±ÞÂ÷ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ÀÚ»ê ÃßÀû ½ÃÀå : Áö¿ªº°

Á¦8Àå ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß 5G ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ ÇコÄÉ¾î ºÐ¾ß 5G ½ÃÀå : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
      • ±âŸ ºÏ¹Ì
  • À¯·´
    • À¯·´ÀÇ ÇコÄÉ¾î ºÐ¾ß 5G ½ÃÀå : ±¹°¡º°
      • µ¶ÀÏ
      • ¿µ±¹
      • ÇÁ¶û½º
      • ·¯½Ã¾Æ
      • ½ºÆäÀÎ
      • ÀÌÅ»¸®¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄÉ¾î ºÐ¾ß 5G ½ÃÀå : ±¹°¡º°
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • Çѱ¹
      • È£ÁÖ
      • ¸»·¹À̽þÆ
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇコÄÉ¾î ºÐ¾ß 5G ½ÃÀå : ±¹°¡º°
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ³²¾ÆÇÁ¸®Ä«
      • ³ªÀÌÁö¸®¾Æ
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • AT&T, Inc
  • Verizon Communications, Inc
  • Ericsson AB
  • Huawei Technologies Co., Ltd.(Huawei Investment & Holding Co., Ltd.)
  • Cisco Systems, Inc
  • Orange SA
  • Samsung Electronics Co, Ltd.(Samsung Group)
  • Nokia Corporation
  • NEC Corporation
  • BT Group plc

Á¦10Àå ÇコÄÉ¾î ºÐ¾ß 5G ½ÃÀåÀÇ ¼º°ø Çʼö Á¶°Ç

AJY 24.12.05

The Global 5G In Healthcare Market size is expected to reach $627.3 billion by 2031, rising at a market growth of 39.5% CAGR during the forecast period.

The segment's expansion is driven by the growing demand for continuous health monitoring solutions and the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and hypertension. The ultra-low latency and high-speed connectivity of 5G networks enable real-time transmission of patient data from wearable devices and IoT-enabled sensors to healthcare providers, ensuring timely interventions and improved patient outcomes. This capability is especially advantageous in remote and underserved regions, where access to in-person medical treatment is restricted, as it enables the management of healthcare in a cost-effective and efficient manner. Thus, the remote patient monitoring segment witnessed 55% revenue share in the 5G in healthcare market in 2023.

The major strategies followed by the market participants are Partnership as the key developmental strategy to keep pace with the changing demands of end users. For instance, In October, 2024, Nokia expanded its multi-year partnership with NTT Data, a global digital business and IT services company, to drive private 5G adoption across various industries including smart cities and airports. This partnership focuses on offering low-latency, high-security private 5G networks to improve operations and enable real-time data sharing. Additionally, In August, 2024, Nokia Corporation came into partnership with Bounteous x Accolite, a global consultancy in digital transformation, to utilize its Network as Code platform and developer portal. This collaboration aims to develop innovative 5G use cases in healthcare, such as improving ambulance response times through location tracking. The partnership will also allow developers to leverage 5G network capabilities to create new applications, enhancing services across various industries, including healthcare.

Market Growth Factors

The demand for telemedicine has surged in recent years, driven by the transformative capabilities of 5G technology, which has revolutionized how healthcare is delivered. Telemedicine has become indispensable for the provision of medical care remotely, thereby eliminating the necessity for in-person visits to healthcare facilities.

Additionally, powered by 5G technology, remote patient monitoring has reached new heights, enabling the continuous transmission of patient data from virtually anywhere to healthcare facilities. The uninterrupted transmission of data from wearable devices, sensors, or other monitoring equipment is guaranteed by the ultra-fast speeds and minimal latency of 5G networks. Thus, by enabling continuous monitoring and effective management of chronic diseases, 5G is reshaping the healthcare landscape.

Market Restraining Factors

The deployment of sector involves a significant financial commitment, which can challenge its widespread adoption. Establishing a robust 5G infrastructure requires the installation of numerous base stations and specialized network hardware to ensure seamless connectivity and coverage. Hence, high initial infrastructure costs remain a significant barrier to the widespread adoption of 5G in healthcare.

Component Outlook

Based on component, the market is bifurcated into hardware and services. The hardware segment garnered 67% revenue share in the market in 2023. Hospitals and healthcare facilities require advanced hardware components, such as 5G-compatible IoT devices, routers, and diagnostic equipment, to support high-speed connectivity and seamless data transmission. The growing reliance on remote patient monitoring systems and wearable health devices further fuels the demand for 5G hardware.

End Use Outlook

On the basis of end use, the market is classified into healthcare providers, healthcare payers, and others. The healthcare payers segment recorded 24% revenue share in the market in 2023. Insurance companies and other payers are adopting 5G to improve claims processing, fraud detection, and member services by leveraging real-time data transmission and AI-driven insights.

Application Outlook

By application, the market is divided into remote patient monitoring, connected medical devices, AR/VR, connected ambulance, and asset tracking. The AR/VR segment procured 13% revenue share in the market in 2023. This segment is being driven by the increasing utilization of augmented and virtual reality in patient therapy, surgical simulations, and medical training. 5G's high bandwidth and low latency ensure that AR/VR applications deliver immersive, real-time experiences, which are critical for robotic surgeries and virtual consultations.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment recorded 32% revenue share in the market in 2023. European countries are increasingly adopting 5G-enabled technologies to enhance telemedicine, optimize hospital workflows, and facilitate cross-border data sharing for collaborative research and care delivery.

Recent Strategies Deployed in the Market

  • Oct-2024: Nokia expanded its multi-year partnership with NTT Data, a global digital business and IT services company, to drive private 5G adoption across various industries including smart cities and airports. This partnership focuses on offering low-latency, high-security private 5G networks to improve operations and enable real-time data sharing.
  • Sep-2024: Ericsson released two new routers, the ruggedized R980 for AI, vehicle networks, and mission-critical IoT, and the compact S400 for IoT applications like digital signage and building controls. Both offer advanced 5G connectivity, security, and operational efficiency, supporting industries' increasing need for reliable, high-performance IoT solutions and network management.
  • Aug-2024: Nokia Corporation came into partnership with Bounteous x Accolite, a global consultancy in digital transformation, to utilize its Network as Code platform and developer portal. This collaboration aims to develop innovative 5G use cases in healthcare, such as improving ambulance response times through location tracking. The partnership will also allow developers to leverage 5G network capabilities to create new applications, enhancing services across various industries, including healthcare.
  • Aug-2024: Ericsson AB partnered with Uscellular, a mobile network company, to enhance 5G transport infrastructure in rural U.S., improving internet speed, capacity, and reliability. Using Ericsson's Router 6000 and new Router 6671, the collaboration supports mid-band 5G deployment, enabling services like precision agriculture, remote education, and telemedicine to boost rural digitalization and local economies.
  • Aug-2024: AT&T Inc. partnered with Oracle, a technology company, to leverage the operator's 5G network and programmable APIs for delivering cloud applications across industries like telehealth and utility management. Their collaboration enables IoT connectivity and near real-time communications, enhancing performance and reliability while simplifying integration for businesses, particularly in public safety.

List of Key Companies Profiled

  • AT&T Inc.
  • Verizon Communications, Inc.
  • Ericsson AB
  • Cisco Systems, Inc.
  • Nokia Corporation
  • Huawei Technologies Co., Ltd. (Huawei Investment & Holding Co., Ltd.)
  • Orange S.A.
  • Samsung Electronics Co., Ltd. (Samsung Health)
  • NEC Corporation
  • BT Group plc

Global 5G In Healthcare Market Report Segmentation

By Component

  • Hardware
  • Services

By End Use

  • Healthcare Providers
  • Healthcare Payers
  • Other End Use

By Application

  • Remote Patient Monitoring
  • Connected Medical Devices
  • AR/VR
  • Connected Ambulance
  • Asset Tracking

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global 5G In Healthcare Market, by Component
    • 1.4.2 Global 5G In Healthcare Market, by End Use
    • 1.4.3 Global 5G In Healthcare Market, by Application
    • 1.4.4 Global 5G In Healthcare Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
  • 4.3 Market Share Analysis, 2023
  • 4.4 Top Winning Strategies
    • 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
    • 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jan - 2024, Oct) Leading Players
  • 4.5 Porter Five Forces Analysis

Chapter 5. Global 5G In Healthcare Market by Component

  • 5.1 Global Hardware Market by Region
  • 5.2 Global Services Market by Region

Chapter 6. Global 5G In Healthcare Market by End Use

  • 6.1 Global Healthcare Providers Market by Region
  • 6.2 Global Healthcare Payers Market by Region
  • 6.3 Global Other End Use Market by Region

Chapter 7. Global 5G In Healthcare Market by Application

  • 7.1 Global Remote Patient Monitoring Market by Region
  • 7.2 Global Connected Medical Devices Market by Region
  • 7.3 Global AR/VR Market by Region
  • 7.4 Global Connected Ambulance Market by Region
  • 7.5 Global Asset Tracking Market by Region

Chapter 8. Global 5G In Healthcare Market by Region

  • 8.1 North America 5G In Healthcare Market
    • 8.1.1 North America 5G In Healthcare Market by Component
      • 8.1.1.1 North America Hardware Market by Region
      • 8.1.1.2 North America Services Market by Region
    • 8.1.2 North America 5G In Healthcare Market by End Use
      • 8.1.2.1 North America Healthcare Providers Market by Country
      • 8.1.2.2 North America Healthcare Payers Market by Country
      • 8.1.2.3 North America Other End Use Market by Country
    • 8.1.3 North America 5G In Healthcare Market by Application
      • 8.1.3.1 North America Remote Patient Monitoring Market by Country
      • 8.1.3.2 North America Connected Medical Devices Market by Country
      • 8.1.3.3 North America AR/VR Market by Country
      • 8.1.3.4 North America Connected Ambulance Market by Country
      • 8.1.3.5 North America Asset Tracking Market by Country
    • 8.1.4 North America 5G In Healthcare Market by Country
      • 8.1.4.1 US 5G In Healthcare Market
        • 8.1.4.1.1 US 5G In Healthcare Market by Component
        • 8.1.4.1.2 US 5G In Healthcare Market by End Use
        • 8.1.4.1.3 US 5G In Healthcare Market by Application
      • 8.1.4.2 Canada 5G In Healthcare Market
        • 8.1.4.2.1 Canada 5G In Healthcare Market by Component
        • 8.1.4.2.2 Canada 5G In Healthcare Market by End Use
        • 8.1.4.2.3 Canada 5G In Healthcare Market by Application
      • 8.1.4.3 Mexico 5G In Healthcare Market
        • 8.1.4.3.1 Mexico 5G In Healthcare Market by Component
        • 8.1.4.3.2 Mexico 5G In Healthcare Market by End Use
        • 8.1.4.3.3 Mexico 5G In Healthcare Market by Application
      • 8.1.4.4 Rest of North America 5G In Healthcare Market
        • 8.1.4.4.1 Rest of North America 5G In Healthcare Market by Component
        • 8.1.4.4.2 Rest of North America 5G In Healthcare Market by End Use
        • 8.1.4.4.3 Rest of North America 5G In Healthcare Market by Application
  • 8.2 Europe 5G In Healthcare Market
    • 8.2.1 Europe 5G In Healthcare Market by Component
      • 8.2.1.1 Europe Hardware Market by Country
      • 8.2.1.2 Europe Services Market by Country
    • 8.2.2 Europe 5G In Healthcare Market by End Use
      • 8.2.2.1 Europe Healthcare Providers Market by Country
      • 8.2.2.2 Europe Healthcare Payers Market by Country
      • 8.2.2.3 Europe Other End Use Market by Country
    • 8.2.3 Europe 5G In Healthcare Market by Application
      • 8.2.3.1 Europe Remote Patient Monitoring Market by Country
      • 8.2.3.2 Europe Connected Medical Devices Market by Country
      • 8.2.3.3 Europe AR/VR Market by Country
      • 8.2.3.4 Europe Connected Ambulance Market by Country
      • 8.2.3.5 Europe Asset Tracking Market by Country
    • 8.2.4 Europe 5G In Healthcare Market by Country
      • 8.2.4.1 Germany 5G In Healthcare Market
        • 8.2.4.1.1 Germany 5G In Healthcare Market by Component
        • 8.2.4.1.2 Germany 5G In Healthcare Market by End Use
        • 8.2.4.1.3 Germany 5G In Healthcare Market by Application
      • 8.2.4.2 UK 5G In Healthcare Market
        • 8.2.4.2.1 UK 5G In Healthcare Market by Component
        • 8.2.4.2.2 UK 5G In Healthcare Market by End Use
        • 8.2.4.2.3 UK 5G In Healthcare Market by Application
      • 8.2.4.3 France 5G In Healthcare Market
        • 8.2.4.3.1 France 5G In Healthcare Market by Component
        • 8.2.4.3.2 France 5G In Healthcare Market by End Use
        • 8.2.4.3.3 France 5G In Healthcare Market by Application
      • 8.2.4.4 Russia 5G In Healthcare Market
        • 8.2.4.4.1 Russia 5G In Healthcare Market by Component
        • 8.2.4.4.2 Russia 5G In Healthcare Market by End Use
        • 8.2.4.4.3 Russia 5G In Healthcare Market by Application
      • 8.2.4.5 Spain 5G In Healthcare Market
        • 8.2.4.5.1 Spain 5G In Healthcare Market by Component
        • 8.2.4.5.2 Spain 5G In Healthcare Market by End Use
        • 8.2.4.5.3 Spain 5G In Healthcare Market by Application
      • 8.2.4.6 Italy 5G In Healthcare Market
        • 8.2.4.6.1 Italy 5G In Healthcare Market by Component
        • 8.2.4.6.2 Italy 5G In Healthcare Market by End Use
        • 8.2.4.6.3 Italy 5G In Healthcare Market by Application
      • 8.2.4.7 Rest of Europe 5G In Healthcare Market
        • 8.2.4.7.1 Rest of Europe 5G In Healthcare Market by Component
        • 8.2.4.7.2 Rest of Europe 5G In Healthcare Market by End Use
        • 8.2.4.7.3 Rest of Europe 5G In Healthcare Market by Application
  • 8.3 Asia Pacific 5G In Healthcare Market
    • 8.3.1 Asia Pacific 5G In Healthcare Market by Component
      • 8.3.1.1 Asia Pacific Hardware Market by Country
      • 8.3.1.2 Asia Pacific Services Market by Country
    • 8.3.2 Asia Pacific 5G In Healthcare Market by End Use
      • 8.3.2.1 Asia Pacific Healthcare Providers Market by Country
      • 8.3.2.2 Asia Pacific Healthcare Payers Market by Country
      • 8.3.2.3 Asia Pacific Other End Use Market by Country
    • 8.3.3 Asia Pacific 5G In Healthcare Market by Application
      • 8.3.3.1 Asia Pacific Remote Patient Monitoring Market by Country
      • 8.3.3.2 Asia Pacific Connected Medical Devices Market by Country
      • 8.3.3.3 Asia Pacific AR/VR Market by Country
      • 8.3.3.4 Asia Pacific Connected Ambulance Market by Country
      • 8.3.3.5 Asia Pacific Asset Tracking Market by Country
    • 8.3.4 Asia Pacific 5G In Healthcare Market by Country
      • 8.3.4.1 China 5G In Healthcare Market
        • 8.3.4.1.1 China 5G In Healthcare Market by Component
        • 8.3.4.1.2 China 5G In Healthcare Market by End Use
        • 8.3.4.1.3 China 5G In Healthcare Market by Application
      • 8.3.4.2 Japan 5G In Healthcare Market
        • 8.3.4.2.1 Japan 5G In Healthcare Market by Component
        • 8.3.4.2.2 Japan 5G In Healthcare Market by End Use
        • 8.3.4.2.3 Japan 5G In Healthcare Market by Application
      • 8.3.4.3 India 5G In Healthcare Market
        • 8.3.4.3.1 India 5G In Healthcare Market by Component
        • 8.3.4.3.2 India 5G In Healthcare Market by End Use
        • 8.3.4.3.3 India 5G In Healthcare Market by Application
      • 8.3.4.4 South Korea 5G In Healthcare Market
        • 8.3.4.4.1 South Korea 5G In Healthcare Market by Component
        • 8.3.4.4.2 South Korea 5G In Healthcare Market by End Use
        • 8.3.4.4.3 South Korea 5G In Healthcare Market by Application
      • 8.3.4.5 Australia 5G In Healthcare Market
        • 8.3.4.5.1 Australia 5G In Healthcare Market by Component
        • 8.3.4.5.2 Australia 5G In Healthcare Market by End Use
        • 8.3.4.5.3 Australia 5G In Healthcare Market by Application
      • 8.3.4.6 Malaysia 5G In Healthcare Market
        • 8.3.4.6.1 Malaysia 5G In Healthcare Market by Component
        • 8.3.4.6.2 Malaysia 5G In Healthcare Market by End Use
        • 8.3.4.6.3 Malaysia 5G In Healthcare Market by Application
      • 8.3.4.7 Rest of Asia Pacific 5G In Healthcare Market
        • 8.3.4.7.1 Rest of Asia Pacific 5G In Healthcare Market by Component
        • 8.3.4.7.2 Rest of Asia Pacific 5G In Healthcare Market by End Use
        • 8.3.4.7.3 Rest of Asia Pacific 5G In Healthcare Market by Application
  • 8.4 LAMEA 5G In Healthcare Market
    • 8.4.1 LAMEA 5G In Healthcare Market by Component
      • 8.4.1.1 LAMEA Hardware Market by Country
      • 8.4.1.2 LAMEA Services Market by Country
    • 8.4.2 LAMEA 5G In Healthcare Market by End Use
      • 8.4.2.1 LAMEA Healthcare Providers Market by Country
      • 8.4.2.2 LAMEA Healthcare Payers Market by Country
      • 8.4.2.3 LAMEA Other End Use Market by Country
    • 8.4.3 LAMEA 5G In Healthcare Market by Application
      • 8.4.3.1 LAMEA Remote Patient Monitoring Market by Country
      • 8.4.3.2 LAMEA Connected Medical Devices Market by Country
      • 8.4.3.3 LAMEA AR/VR Market by Country
      • 8.4.3.4 LAMEA Connected Ambulance Market by Country
      • 8.4.3.5 LAMEA Asset Tracking Market by Country
    • 8.4.4 LAMEA 5G In Healthcare Market by Country
      • 8.4.4.1 Brazil 5G In Healthcare Market
        • 8.4.4.1.1 Brazil 5G In Healthcare Market by Component
        • 8.4.4.1.2 Brazil 5G In Healthcare Market by End Use
        • 8.4.4.1.3 Brazil 5G In Healthcare Market by Application
      • 8.4.4.2 Argentina 5G In Healthcare Market
        • 8.4.4.2.1 Argentina 5G In Healthcare Market by Component
        • 8.4.4.2.2 Argentina 5G In Healthcare Market by End Use
        • 8.4.4.2.3 Argentina 5G In Healthcare Market by Application
      • 8.4.4.3 UAE 5G In Healthcare Market
        • 8.4.4.3.1 UAE 5G In Healthcare Market by Component
        • 8.4.4.3.2 UAE 5G In Healthcare Market by End Use
        • 8.4.4.3.3 UAE 5G In Healthcare Market by Application
      • 8.4.4.4 Saudi Arabia 5G In Healthcare Market
        • 8.4.4.4.1 Saudi Arabia 5G In Healthcare Market by Component
        • 8.4.4.4.2 Saudi Arabia 5G In Healthcare Market by End Use
        • 8.4.4.4.3 Saudi Arabia 5G In Healthcare Market by Application
      • 8.4.4.5 South Africa 5G In Healthcare Market
        • 8.4.4.5.1 South Africa 5G In Healthcare Market by Component
        • 8.4.4.5.2 South Africa 5G In Healthcare Market by End Use
        • 8.4.4.5.3 South Africa 5G In Healthcare Market by Application
      • 8.4.4.6 Nigeria 5G In Healthcare Market
        • 8.4.4.6.1 Nigeria 5G In Healthcare Market by Component
        • 8.4.4.6.2 Nigeria 5G In Healthcare Market by End Use
        • 8.4.4.6.3 Nigeria 5G In Healthcare Market by Application
      • 8.4.4.7 Rest of LAMEA 5G In Healthcare Market
        • 8.4.4.7.1 Rest of LAMEA 5G In Healthcare Market by Component
        • 8.4.4.7.2 Rest of LAMEA 5G In Healthcare Market by End Use
        • 8.4.4.7.3 Rest of LAMEA 5G In Healthcare Market by Application

Chapter 9. Company Profiles

  • 9.1 AT&T, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
      • 9.1.5.2 Product Launches and Product Expansions:
    • 9.1.6 SWOT Analysis
  • 9.2 Verizon Communications, Inc.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental Analysis
    • 9.2.4 Recent strategies and developments:
      • 9.2.4.1 Partnerships, Collaborations, and Agreements:
    • 9.2.5 SWOT Analysis
  • 9.3 Ericsson AB
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Partnerships, Collaborations, and Agreements:
    • 9.3.6 SWOT Analysis
  • 9.4 Huawei Technologies Co., Ltd. (Huawei Investment & Holding Co., Ltd.)
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expenses
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Product Launches and Product Expansions:
    • 9.4.6 SWOT Analysis
  • 9.5 Cisco Systems, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
    • 9.5.6 SWOT Analysis
  • 9.6 Orange S.A.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental Analysis
    • 9.6.4 Recent strategies and developments:
      • 9.6.4.1 Product Launches and Product Expansions:
      • 9.6.4.2 Acquisition and Mergers:
  • 9.7 Samsung Electronics Co., Ltd. (Samsung Group)
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Partnerships, Collaborations, and Agreements:
    • 9.7.6 SWOT Analysis
  • 9.8 Nokia Corporation
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expense
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Partnerships, Collaborations, and Agreements:
    • 9.8.6 SWOT Analysis
  • 9.9 NEC Corporation
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expenses
    • 9.9.5 SWOT Analysis
  • 9.10. BT Group plc
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
    • 9.10.4 Research & Development Expenses
    • 9.10.5 SWOT Analysis

Chapter 10. Winning Imperatives of 5G In Healthcare Market

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦